|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dermatitis, Atopic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dermatitis | |||||
| 3 | More general conditions related to this trial | ||||
| Genetic Diseases, Inborn | |||||
| Hypersensitivity | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| Skin Diseases, Eczematous | |||||
| Skin Diseases, Genetic | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Pimecrolimus | |||||
| Tacrolimus | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Dermatologic Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Novartis | |||||